• Skip to main content

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

News

News

z3admin / August 2, 2016

Aug 02, 2016 / Calabrian

SK Capital Completes the Sale of Calabrian to Ineos Enterprises

Kingwood, Texas, August 2, 2016 – SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and healthcare sectors, announced …

➞

z3admin / July 20, 2016

Jul 20, 2016 / Noramco, SK Capital, Tasmanian Alkaloids

SK Capital Announces New Organizational Structure and Expanded Leadership Team At Noramco And Tasmanian Alkaloids

New York, July 20, 2016 - SK Capital, a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors, announced …

➞

z3admin / June 23, 2016

Jun 23, 2016 / SK Capital

SK Capital Promotes Three Investment Professionals

New York – June 23, 2016 – SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors, …

➞

z3admin / January 7, 2016

Jan 07, 2016 / TPC Group

TPC Group Announces New Chief Executive Officer

Houston (January 7, 2016) – TPC Group announced today that Ed Dineen has been appointed Chairman, President and Chief Executive Officer of the Company. Mr. …

➞

z3admin / December 14, 2015

Dec 14, 2015 / Capvest, IBA Molecular, SK Capital

SK Capital Announces Sale of IBA Molecular to Capvest

Paris, France, December 14, 2015 – SK Capital (“SK”), a private investment firm focused on the specialty materials, chemicals and healthcare sectors, announced …

➞

z3admin / August 26, 2015

Aug 26, 2015 / Halo Pharmaceutical

Halo Pharmaceutical Makes Key Additions to Management Team

Whippany, New Jersey, August 26, 2015 – Halo Pharmaceutical, a rapidly growing Contract Development and Manufacturing Organization (CDMO), is pleased to …

➞

  • ➞
  • Go to page 1
  • Interim pages omitted …
  • Go to page 17
  • Go to page 18
  • Go to page 19
  • Go to page 20
  • Go to page 21
  • Interim pages omitted …
  • Go to page 25
  • ➞

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login